Search Results 181-190 of 11772 for Drug-resistant TB
... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf And Enzalutamide For The Treatment Of Metastatic Castration-Resistant Prostate Cancer, TraPPer Study · Share ...
Learn about the prevention and treatment of this disease that causes serious illness around the world.
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
The aim of this study is two fold: First the investigators want to determine the safe and most effective dose of subcutaneous (SQ) BNP in subjects with ...
This medicine is also used to slow the rate of decline in lung function in people with systemic sclerosis-associated interstitial lung disease. Nintedanib ...
The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in patients ...
Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.